AI assistant
Hengxin Technology Ltd. — AGM Information 2015
Mar 20, 2015
49674_rns_2015-03-20_818b7c79-d381-4b00-8b54-0582fc86fb50.pdf
AGM Information
Open in viewerOpens in your device viewer
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
==> picture [145 x 46] intentionally omitted <==
HENGXIN TECHNOLOGY LTD. 亨 鑫 科 技 有 限 公 司[*]
(carrying on business in Hong Kong as HX Singapore Ltd.)
(Incorporated in Singapore with limited liability) (Singapore Registration No.: 200414927H) (Hong Kong Stock Code: 1085) (Singapore Stock Code: I85)
NOTICE OF ANNUAL GENERAL MEETING
NOTICE IS HEREBY GIVEN that the annual general meeting (the ‘‘Annual General Meeting’’) of Hengxin Technology Ltd. (the ‘‘Company’’) will be held at Meeting Room 310 (Level 3), Suntec Convention & Exhibition Centre, 1 Raffles Boulevard, Suntec City, Singapore 039593 on Monday, 27 April 2015 at 2: 30 p.m. and at any adjournment thereof for the following purposes:
AS ORDINARY BUSINESS
- To receive and adopt the directors’ report and the audited financial statements of the Company and the Group for the year ended 31 December 2014 together with the auditors’ report thereon.
(Resolution 1)
-
To note the retirement of Mr Tay Ah Kong Bernard as a Director of the Company pursuant to Article 89 of the Company’s Articles of Association. (Mr Tay Ah Kong Bernard who is retiring pursuant to Article 89 of the Company’s Articles of Association has indicated that he will not be seeking re-election as a Director of the Company.)
-
To re-elect the following directors of the Company (the ‘‘Directors’’) retiring pursuant to the Articles of Association of the Company:
-
Mr. Xu Guoqiang (Article 89)
-
Mr. Cui Wei (Article 88) Dr. Li Jun (Article 88) Mr. Pu Hong (Article 88) [See Explanatory Note (i)]
(Resolution 2) (Resolution 3) (Resolution 4) (Resolution 5)
- For identification purpose only
– 1 –
- To approve the payment of additional Directors’ fees of S$12,986 for the financial year ended 31 December 2014.
(Resolution 6)
- To approve the payment of Directors’ fees of S$116,000 and HK$1,635,935 for the financial year ending 31 December 2015 (2014:S$356,000).
(Resolution 7)
- To re-appoint Messrs Deloitte & Touche LLP as the auditors of the Company and to authorise the Directors to fix their remuneration.
(Resolution 8)
- To transact any other ordinary business which may be properly transacted at an annual general meeting.
AS SPECIAL BUSINESS
To consider and if thought fit, to pass the following resolutions as Ordinary Resolutions, with or without any modifications:
- Authority to issue shares in the capital of the Company pursuant to Section 161 of the Singapore Companies Act, Cap. 50 (the ‘‘Companies Act’’), and the Rules Governing the Listing of Securities (the ‘‘Hong Kong Listing Rules’’) of the Stock Exchange of Hong Kong Limited (the ‘‘SEHK’’).
That pursuant to Section 161 of the Companies Act and the Hong Kong Listing Rules, the Directors be authorised and empowered to:
-
(a) (i) issue shares in the Company (the ‘‘Shares’’) whether by way of rights, bonus or otherwise; and/or
-
(ii) make or grant offers, agreements or options (collectively, the ‘‘Instruments’’) that might or would require shares to be issued, including but not limited to the creation and issue of (as well as adjustments to) options, warrants, debentures or other instruments convertible into shares, at any time and upon such terms and conditions and for such purposes and to such persons as the Directors may in their absolute discretion deem fit; and
-
(b) (notwithstanding the authority conferred by this Resolution may have ceased to be in force) issue shares in pursuance of any Instrument made or granted by the Directors while this Resolution was in force,
(the ‘‘Share Issue Mandate’’)
– 2 –
provided that:
-
(1) the aggregate number of shares (including shares to be issued in pursuance of the Instruments, made or granted pursuant to this Resolution), otherwise than pursuant to (i) a Rights Issue (as hereinafter defined); or (ii) an issue of shares upon the exercise of options which may be granted under any share option scheme or under any option scheme or similar arrangement for the time being adopted for the grant or issue to officers and/or employees of the Company and/or any of its subsidiaries or any other person of shares or rights to acquire shares of the Company; or (iii) any scrip dividend schemes or similar arrangements providing for the allotment and issue of shares in lieu of the whole or part of a dividend on shares of the Company in accordance with the articles of association of the Company; or (iv) a specific authority granted by the shareholders of the Company in general meeting, shall not exceed the aggregate of twenty per cent. (20%) of the total number of issued shares (excluding treasury shares) in the capital of the Company (as calculated in accordance with sub-paragraph (2) below);
-
(2) (subject to such calculation as may be prescribed by the SEHK) for the purpose of determining the aggregate number of shares and Instruments that may be issued under subparagraph (1) above, the percentage of issued shares and Instruments shall be based on the number of issued shares (excluding treasury shares) in the capital of the Company at the time of the passing of this Resolution, after adjusting for:
-
(a) new shares arising from the conversion or exercise of the Instruments or any convertible securities;
-
(b) new shares arising from exercising share options or vesting of share awards outstanding and subsisting at the time of the passing of this Resolution; and
-
(c) any subsequent consolidation or subdivision of shares;
-
(3) in exercising the Share Issue Mandate conferred by this Resolution, the Company shall comply with the provisions of the Hong Kong Listing Rules for the time being in force (unless such compliance has been waived by the SEHK) and the articles of association of the Company; and
– 3 –
- (4) unless revoked or varied by the Company in a general meeting, the Share Issue Mandate shall continue in force (i) until the conclusion of the next annual general meeting of the Company or the date by which the next annual general meeting of the Company is required by law to be held, whichever is earlier or (ii) in the case of shares to be issued in pursuance of the Instruments, made or granted pursuant to this Resolution, until the issuance of such shares in accordance with the terms of the Instruments, whichever is earlier.
[See Explanatory Note (ii)]
(Resolution 9)
9. Adoption of New Share Purchase Mandate
That for the purposes of Sections 76C and 76E of the Singapore Companies Act, Cap. 50, the Directors be and are hereby authorised to make purchases or otherwise acquire issued shares in the capital of the Company from time to time (whether by way of Market Purchases or Off-Market Purchases on an equal access scheme) of up to ten per cent. (10%) of the total number of issued shares (excluding treasury shares) in the capital of the Company (as ascertained as at the date of the the Annual General Meeting) at the price of up to but not exceeding the Maximum Price as defined in paragraph 1.3.4 under Appendix II attached to the Company’s circular dated 23 March 2015 (the ‘‘Circular’’), in accordance with the ‘‘Authority and limits of the New Share Purchase Mandate’’ set in the Circular, and this mandate shall, unless revoked or varied by the Company in general meeting, continue in force until the conclusion of the next annual general meeting of the Company or the date by which the next annual general meeting of the Company is required by law to be held, whichever is earlier.
[See Explanatory Note (iii)]
(Resolution 10)
– 4 –
10. Authority to issue shares under the Hengxin Share Option Scheme
That pursuant to Section 161 of the Companies Act, the Directors be authorised and empowered to offer and grant options (the ‘‘Options’’) under the share option scheme of the Company (the ‘‘Scheme’’) and to allot and issue from time to time such number of shares in the capital of the Company as may be required to be transferred or issued pursuant to the exercise of the Options granted by the Company under the Scheme, whether granted during the subsistence of this authority or otherwise, provided always that the aggregate number of additional ordinary shares to be issued pursuant to the Scheme shall not exceed fifteen per cent (15%) of the total number of issued shares (excluding treasury shares) in the capital of the Company from time to time and that such authority shall, unless revoked or varied by the Company in a general meeting, continue in force until the conclusion of the next annual general meeting of the Company or the date by which the next annual general meeting of the Company is required by law to be held, whichever is earlier. [See Explanatory Note (iv)]
(Resolution 11)
By Order of the Board of Hengxin Technology Ltd. Shirley Lim Guat Hua Company Secretary Singapore, 23 March 2015
Explanatory Notes:
- (i) Mr. Xu Guoqiang will, upon re-election as a Director of the Company, remain as an Executive Director and he will be considered non-independent.
Mr. Cui Wei will, upon re-election as a Director of the Company, remain as a Non-Executive Director and member of the remuneration committee and nominating committee of the Company and he will be considered non-independent.
Dr. Li Jun will, upon re-election as a Director of the Company, remain as an Independent Non-Executive Director, Chairman of the Remuneration Committee, and as a member of the audit committee and nominating committee of the Company and he will be considered independent.
Mr. Pu Hong will, upon re-election as a Director of the Company, remain as an Independent Non-Executive Director, a member of the audit committee, remuneration committee and nominating committee of the Company and he will be considered independent.
- (ii) The Ordinary Resolution 9 above, if passed, will empower the Directors from the date of this Annual General Meeting until the date of the next annual general meeting of the Company, or the date by which the next annual general meeting of the Company is required by law to be held or such authority is varied or revoked by the Company in a general meeting, whichever is the earlier, to issue shares, make or grant instruments convertible into shares and to issue shares pursuant to such Instruments, up to a number not exceeding the aggregate of twenty per cent. (20%) of the existing issued share capital of the Company.
– 5 –
For determining the aggregate number of shares that may be issued, the percentage of issued shares in the capital of the Company will be calculated based on the total number of issued shares (excluding treasury shares) in the capital of the Company at the time this Ordinary Resolution is passed after adjusting for new shares arising from the conversion or exercise of the Instruments or any convertible securities, the exercise of share options or the vesting of share awards outstanding or subsisting at the time when this Ordinary Resolution is passed and any subsequent consolidation or subdivision of shares.
For the purpose of this resolution,
‘‘Rights Issue’’ means an offer of shares of the Company or issue of options, warrants or other securities giving the right to subscribe for shares of the Company, open for a period fixed by the Directors to holders of shares whose names appear on the register of members of the Company (and, where appropriate, to holders of other securities of the Company entitled to the offer) on a fixed record date in proportion to their then holdings of such shares (or, where appropriate, such other securities) (subject in all cases to such exclusions or other arrangements as the Directors may deem necessary or expedient in relation to fractional entitlements or having regard to any restrictions or obligations under the laws of, or the requirements of any recognised regulatory body or any stock exchange in, any territory applicable to the Company).
-
(iii) The Ordinary Resolution 10 above, if passed, will empower the Directors from the date of the Annual General Meeting until the next annual general meeting of the Company or the date by which the next annual general meeting of the Company is required by law to be held, whichever is the earlier, to purchase or acquire ordinary shares of the Company by way of Market Purchases or Off-Market Purchases on an equal access scheme of up to ten per cent. (10%) of the total number of issued shares (excluding treasury shares) in the capital of the Company at the Maximum Price as defined under paragraph 1.3.4 under Appendix II attached to the Circular, unless this authority is varied or revoked by the Company in a general meeting. The rationale for, the authority and limitation on, the sources of funds to be used for the purchase or acquisition including the amount of financing and the financial effects of the purchase or acquisition of Shares by the Company pursuant to the Share Purchase Mandate are set out in greater detail in the Circular.
-
(iv) The Ordinary Resolution 11 above, if passed, will empower the Directors from the date of the above Annual General Meeting until the next annual general meeting of the Company or the date by which the next annual general meeting of the Company is required by law to be held or such authority is varied or revoked by the Company in a general meeting, whichever is the earlier, to issue shares in the Company pursuant to the exercise of options granted or to be granted under the Scheme up to a number not exceeding in total (for the entire duration of the Scheme) fifteen per cent. (15%) of the issued shares in the capital of the Company from time to time.
IMPORTANT: Notwithstanding the passing of the Ordinary Resolution Nos. 9, 10 and 11, the Company shall from time to time comply with the relevant requirements under the Hong Kong Listing Rules in relation to issuance of securities, repurchase of shares and issuance of shares under share option scheme.
Notes:
-
A member of the Company (the ‘‘Member’’) entitled to attend and vote at the Annual General Meeting is entitled to appoint more than one proxy to attend and vote in his/her stead. A proxy need not be a Member. Where a Member appoints more than one proxy, the Member shall specify the proportion of his shares to be represented by each such proxy, failing which the nomination shall be deemed to be alternative.
-
The instrument appointing a proxy, and if the instrument appointing a proxy is signed by an attorney, the letter or power of attorney or a duly certified copy thereof, must be deposited at the Company’s Principal Share Registrar in Singapore, Boardroom Corporate & Advisory Services Pte. Ltd. at 50 Raffles Place, Singapore Land Tower #32-01, Singapore 048623 (for Singapore Shareholders), or at the office of the Company’s Branch Share Registrar in Hong Kong, Tricor Investor Services Limited, at Level 22, Hopewell Centre, 183 Queen’s Road East, Hong Kong (for Hong Kong Shareholders), not less than forty-eight (48) hours before the time appointed for holding the Annual General Meeting.
– 6 –
-
If the Member is a corporation, the instrument appointing a proxy must be executed under seal or the hand of its duly authorised officer or attorney.
-
A depositor whose name appears in the Depository Register (as defined in Section 130A of the Companies Act) of the Company and who is unable to attend personally but wishes to appoint a nominee to attend and vote on his behalf, or if such depositor is a corporation, should complete the depositor proxy form under seal or the hand of its duly authorised officer or attorney and lodge the same at the office of the Company’s Singapore Principal Share Registrar, Boardroom Corporate & Advisory Services Pte. Ltd. at 50 Raffles Place, Singapore Land Tower #32-01, Singapore 048623, not later than forty-eight (48) hours before the time appointed for the Annual General Meeting.
-
The Principal Share Registrar and Branch Share Registrar of the Company will be closed from 16 April 2015 to 27 April 2015 (both days, inclusive), during which period no transfer of Shares will be effected. In order to qualify for attending the Annual General Meeting, all transfers accompanied by the relevant share certificates and transfer forms must be lodged with the Company’s Principal Share Registrar in Singapore, Boardroom Corporate & Advisory Services Pte. Ltd. at 50 Raffles Place, Singapore Land Tower #32-01, Singapore 048623 (for Singapore Shareholders), or at the office of the Company’s Branch Share Registrar in Hong Kong, Tricor Investor Services Limited, at Level 22, Hopewell Centre, 183 Queen’s Road East, Hong Kong (for Hong Kong Shareholders) not later than 4: 30 p.m. on 15 April 2015.
As at the date of announcement, the executive Directors of the Company are Mr. Cui Genxiang and Mr. Xu Guoqiang; the non-executive Director of the Company is Mr. Cui Wei and Ms. Zhang Zhong; and the independent non-executive Directors are Mr. Tay Ah Kong Bernard, Mr. Chee Teck Kwong Patrick, Mr. Tam Chi Kwan Michael, Dr. Li Jun and Mr. Pu Hong.
- For identification purpose only
– 7 –